Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to ILLINGWORTH: Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholester.... (0.08 sec) 

Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia


DR ILLINGWORTH - Annals of internal medicine, 1984 - Am Coll Physicians
Twelve patients with severe heterozygous familial hypercholesterolemia, in whom
other hypolipidemic drug therapy had failed to reduce serum cholesterol levels
to less than 300 mg/dL, were sequentially treated with mevinolin (a ...
Cited by 93 - Related articles - All 3 versions

Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on …


SM GRUNDY, GL VEGA, DW BILHEIMER - Annals of internal medicine, 1985 - Am Coll Physicians
Patients with heterozygous familial hypercholesterolemia have a 50% deficiency
of receptors for plasma low density lipoproteins (LDL) that induces a marked
increase in plasma LDL levels. Two therapeutic measures that seem to ...
Cited by 81 - Related articles - All 3 versions

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. …

- kanazawa-u.ac.jp [PDF] 
H Mabuchi, T Sakai, Y Sakai, A Yoshimura, A …, 1983 - dspace.lib.kanazawa-u.ac.jp
Reduction of serum cholesterol in heterozygous patients with ... Citation New
England Journal of Medicine, 308(11): 609-613 ...
HIRosHIMABuoH1,M.D、,TAKEsHISAKA1,M.D、, ...
Cited by 129 - Related articles - View as HTML - All 4 versions

Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial …


MJ MALLOY, JP KANE, ST KUNITAKE, P TUN - Annals of internal medicine, 1987 - Am Coll Physicians
Objective: To compare the effectiveness of the ternarydrug combination of
colestipol, niacin, and lovastatin with binary combinations of those drugs in
treating patients with familial hypercholesterolemia.
Cited by 80 - Related articles - All 4 versions

Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and …


GL Vega, SM Grundy - JAMA, 1987 - Am Med Assoc
The introduction of inhibitors of cholesterol biosynthesis offers a new approach
to treatment of hypercholesterolemia. One such agent, lovastatin (formerly,
mevinolin), causes significant reductions in plasma cholesterol levels. ...
Cited by 72 - Related articles - All 3 versions

Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year …


J Emmerich, I Aubert, B Bauduceau, A DACHET … - European Heart Journal, 1990 - Eur Soc Cardiology
*Unite de recherches sur les dyslipidemies et I'atherosclerose, INSERM U 32,
Hopital Henri Mondor, Creteil, ^Servicede Medecine Interne et Pathologic
vasculaire, Hopital Saint Louis, and %Service d'Endocrinologie, Hopital d' ...
Cited by 21 - Related articles - All 2 versions

[CITATION] Therapy of hypercholesterolemia with mevinolin and other lipid-lowering drugs


AM Lees, SW Stein, RS Lees - Arteriosclerosis, 1986
Cited by 23 - Related articles

Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia


K Ytre-Arne, A Nordøy - Journal of internal medicine, 1989 - cat.inist.fr
Simvastatin and cholestyramine in the long-term treatment of
hypercholesterolaemia. K YTRE-ARNE, A NORDØY Journal of internal medicine ...
Cited by 24 - Related articles - All 3 versions

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial …

- nih.gov [PDF] 
DR Illingworth, GJ Sexton - Journal of Clinical Investigation, 1984 - pubmedcentral.nih.gov
This work was presented in part at the 56th Scientific Meeting of the American
Heart Association, Anaheim, CA, 1983, and was published in abstract (1983.
Circulation. 68:111-188). Ad4ress correspondence to Dr. Illingworth, The ...
Cited by 93 - Related articles - All 7 versions

Combination drug therapy with HMG CoA reductase inhibitors and bile acid sequestrants …


DW Erkelens - Cardiology, 1990 - content.karger.com
Single-drug therapy is often not sufficient to lower total and low-density
lipoprotein (LDL) cholesterol levels in patients with familial
hypercholesterolemia to desirable or target levels. Therefore, combination ...
Cited by 21 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google